Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 18, 2017 - Issue 6
Submit an article Journal homepage
404
Views
22
CrossRef citations to date
0
Altmetric
Drug Evaluation

Sorafenib for the treatment of breast cancer

Giuseppe BronteDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyView further author information
,
Daniele AndreisUnit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyView further author information
,
Sara BravacciniBiosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyView further author information
,
Roberta MaltoniDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyView further author information
,
Lorenzo CecconettoDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyView further author information
,
Alessio SchironeDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyView further author information
,
Alberto FarolfiDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyView further author information
,
Anna FedeliDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyView further author information
,
Patrizia SerraUnit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyView further author information
,
Caterina DonatiOncology Pharmacy, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyView further author information
,
Dino AmadoriDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyCorrespondence[email protected]
View further author information
&
Andrea RoccaDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, ItalyView further author information
 show all
Pages 621-630 | Received 23 Nov 2016, Accepted 16 Mar 2017, Published online: 07 Apr 2017

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Michela Cortesi, Michele Zanoni, Roberta Maltoni, Sara Ravaioli, Maria Maddalena Tumedei, Francesca Pirini & Sara Bravaccini. (2022) TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer. Expert Opinion on Therapeutic Targets 26:7, pages 593-602.
Read now
Yingjie Ma, Jing Wang, Qin Li & Bangwei Cao. (2021) The Effect of Omega-3 Polyunsaturated Fatty Acid Supplementations on anti-Tumor Drugs in Triple Negative Breast Cancer. Nutrition and Cancer 73:2, pages 196-205.
Read now
Guo Lian, Jia Yuan & Yuan Gao. (2020) In vitro Transport Ability of ABCC2 (G1249A) Polymorphic Variant Towards Anticancer Drugs. OncoTargets and Therapy 13, pages 1413-1419.
Read now

Articles from other publishers (19)

Voitto Känkänen, Micaela Fernandes, Zehua Liu, Jani Seitsonen, Sami-Pekka Hirvonen, Janne Ruokolainen, João F. Pinto, Jouni Hirvonen, Vimalkumar Balasubramanian & Hélder A. Santos. (2023) Microfluidic preparation and optimization of sorafenib-loaded poly(ethylene glycol-block-caprolactone) nanoparticles for cancer therapy applications. Journal of Colloid and Interface Science 633, pages 383-395.
Crossref
Maryam Rahimi, Setareh Talebi Kakroodi & Mansoureh Tajvidi. (2022) The Importance of RTK Signaling Genes and their Inhibitors in Breast Cancer. Journal of Obstetrics, Gynecology and Cancer Research 7:4, pages 258-271.
Crossref
Xiaolian Li, Mingkun Xu, Jiaojiao Shen, Yuqin Li, Shaoping Lin, Min Zhu, Qiongni Pang, Xiujuan Tan & Jing Tang. (2022) Sorafenib inhibits LPS-induced inflammation by regulating Lyn-MAPK-NF-kB/AP-1 pathway and TLR4 expression. Cell Death Discovery 8:1.
Crossref
Hua-Li Wang, Xue Ma, Xin-Yuan Guan, Chen Song, Guo-Bo Li, Ya-Mei Yu & Ling-Ling Yang. (2022) Potential synthetic lethality for breast cancer: A selective sirtuin 2 inhibitor combined with a multiple kinase inhibitor sorafenib. Pharmacological Research 177, pages 106050.
Crossref
Dong Yan, Chunxiao Li, Yantong Zhou, Xue Yan, Weihua Zhi, Haili Qian & Yue Han. (2022) Exploration of Combinational Therapeutic Strategies for HCC Based on TCGA HCC Database. Oncologie 24:1, pages 101-111.
Crossref
Dengke Hong, Jiajia Yang, Jingjing Guo, Yu Zhang & Zhikui Chen. (2021) Ultrasound-Targeted Microbubble Destruction Enhances Inhibitory Effect of Apatinib on Angiogenesis in Triple Negative Breast Carcinoma Xenografts. Analytical Cellular Pathology 2021, pages 1-11.
Crossref
Bruna R. Silva, Rita Rebelo, Juliana M. Rodrigues, Cristina P. R. Xavier, M. Helena Vasconcelos & Maria-João R. P. Queiroz. (2021) Synthesis of Novel Methyl 3-(hetero)arylthieno[3,2-b]pyridine-2-carboxylates and Antitumor Activity Evaluation: Studies In Vitro and In Ovo Grafts of Chick Chorioallantoic Membrane (CAM) with a Triple Negative Breast Cancer Cell Line. Molecules 26:6, pages 1594.
Crossref
Nicola d'Avanzo, Giulia Torrieri, Patrícia Figueiredo, Christian Celia, Donatella Paolino, Alexandra Correia, Karina Moslova, Tambet Teesalu, Massimo Fresta & Hélder A. Santos. (2021) LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy. International Journal of Pharmaceutics 597, pages 120346.
Crossref
Satomi Watanabe, Masayuki Takeda, Tomoyuki Otani, Takeshi Yoshida, Kazuko Sakai, Elizabeth Olek, S. Michael Rothenberg, Jennifer Kherani, Pearl P. French, Kazuto Nishio, Akihiko Ito & Kazuhiko Nakagawa. (2021) Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer . JCO Precision Oncology:5, pages 103-106.
Crossref
Samia A. Elseginy, Rania Hamdy, Varsha Menon, Ahmed M. Almehdi, Raafat El-Awady & Sameh S.M. Soliman. (2020) Design, synthesis, and computational validation of novel compounds selectively targeting HER2-expressing breast cancer. Bioorganic & Medicinal Chemistry Letters 30:24, pages 127658.
Crossref
Alena Liskova, Lenka Koklesova, Marek Samec, Elizabeth Varghese, Mariam Abotaleb, Samson Mathews Samuel, Karel Smejkal, Kamil Biringer, Martin Petras, Dana Blahutova, Ondrej Bugos, Martin Pec, Marian Adamkov, Dietrich Büsselberg, Rachele Ciccocioppo, Mariusz Adamek, Luis Rodrigo, Martin Caprnda, Peter Kruzliak & Peter Kubatka. (2020) Implications of flavonoids as potential modulators of cancer neovascularity. Journal of Cancer Research and Clinical Oncology 146:12, pages 3079-3096.
Crossref
Jing Li, Hongwei Cai, Huihui Sun, Jianbo Qu, Bin Zhao, Xuefeng Hu, Wenjia Li, Zhengming Qian, Xia Yu, Fenghua Kang, Wenxuan Wang, Zhenxin Zou, Baohua Gu & Kangping Xu. (2020) Extracts of Cordyceps sinensis inhibit breast cancer growth through promoting M1 macrophage polarization via NF-κB pathway activation. Journal of Ethnopharmacology 260, pages 112969.
Crossref
Shengxian Zhao, Yin Cao, Zhenzhen Cui, Jiayun Zhang, Zhixiang Pan & Hongyu Hu. (2020) Synthesis and Biological Activity of 2-Arylidene- N -(quinolin-6-yl)hydrazine-1-carboxamides . Journal of Chemistry 2020, pages 1-9.
Crossref
Zhen-Zhen Wang, Tian-Yu Huang, Yong-Fang Gong, Xiao-Ming Zhang, Feng-Wang & Xue-Ying Huang. (2020) Effects of sorafenib on fibroblast-like synoviocyte apoptosis in rats with adjuvant arthritis. International Immunopharmacology 83, pages 106418.
Crossref
Maria Carolina Mangini Prado, Sofia de Almeida Losant Macedo, Giulia Gumiero Guiraldelli, Patricia de Faria Lainetti, Antonio Fernando Leis-Filho, Priscila Emiko Kobayashi, Renee Laufer-Amorim & Carlos Eduardo Fonseca-Alves. (2019) Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors. Frontiers in Oncology 9.
Crossref
Lois M. Mulligan. (2019) GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential. Frontiers in Physiology 9.
Crossref
Ahmed A. Abdelgalil, Hamad M. Alkahtani & Fahad I. Al-Jenoobi. 2019. Profiles of Drug Substances, Excipients, and Related Methodology. Profiles of Drug Substances, Excipients, and Related Methodology 239 266 .
Bhavna S. Paratala, Jon H. Chung, Casey B. Williams, Bahar Yilmazel, Whitney Petrosky, Kirstin Williams, Alexa B. Schrock, Laurie M. Gay, Ellen Lee, Sonia C. Dolfi, Kien Pham, Stephanie Lin, Ming Yao, Atul Kulkarni, Frances DiClemente, Chen Liu, Lorna Rodriguez-Rodriguez, Shridar Ganesan, Jeffrey S. Ross, Siraj M. Ali, Brian Leyland-Jones & Kim M. Hirshfield. (2018) RET rearrangements are actionable alterations in breast cancer. Nature Communications 9:1.
Crossref
Zhen-Zhen Wang, Fei Liu, Yong-Fang Gong, Tian-Yu Huang, Xiao-Ming Zhang & Xue-Ying Huang. (2018) Antiarthritic Effects of Sorafenib in Rats with Adjuvant-Induced Arthritis. The Anatomical Record 301:9, pages 1519-1526.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.